Detalhe da pesquisa
1.
Telemedicine During COVID-19 Pandemic: Lesson Learned from the Lazio Region Infectious Diseases and Emergency Department Network.
J Med Syst
; 46(12): 105, 2022 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473993
2.
Multi-omics approach to COVID-19: a domain-based literature review.
J Transl Med
; 19(1): 501, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876157
3.
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
J Transl Med
; 18(1): 233, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522207
4.
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient.
PLoS Pathog
; 13(1): e1006065, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28056096
5.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Blood
; 129(5): 553-560, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903528
6.
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
Ann Hematol
; 97(5): 821-829, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340761
7.
Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani.
Adv Exp Med Biol
; 972: 103-122, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864803
8.
Short-term economic impact of the Zika virus outbreak.
New Microbiol
; 39(4): 287-289, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004846
9.
Ebola virus disease complicated with viral interstitial pneumonia: a case report.
BMC Infect Dis
; 15: 432, 2015 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471197
10.
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Am J Hematol
; 89(5): 480-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415640
11.
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma.
Blood
; 117(8): 2405-13, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156845
12.
Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome.
BMC Public Health
; 13: 872, 2013 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24053349
13.
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
Cancer
; 118(21): 5265-9, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517301
14.
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.
Cancer
; 118(6): 1574-84, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21932386
15.
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
J Transl Med
; 10: 18, 2012 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289136
16.
Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
Blood
; 115(18): 3726-36, 2010 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20061561
17.
Tuberculosis in sheltered homeless population of Rome: an integrated model of recruitment for risk management.
ScientificWorldJournal
; 2012: 396302, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22448132
18.
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Blood Cancer J
; 12(12): 165, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509740
19.
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.
Blood
; 114(21): 4696-702, 2009 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19667403
20.
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
Haematologica
; 96(2): 277-83, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20971821